Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1995 Oct;103(Suppl 7):35–38. doi: 10.1289/ehp.95103s735

Cross talk between peptide growth factor and estrogen receptor signaling systems.

D M Ignar-Trowbridge 1, M Pimentel 1, C T Teng 1, K S Korach 1, J A McLachlan 1
PMCID: PMC1518889  PMID: 8593872

Abstract

Epidermal growth factor reproduces many of the effects of estrogen on the murine female reproductive tract and may partially mediate estrogen-induced growth and differentiation. The mechanism by which the actions of estrogens and epidermal growth factor (EGF) converge is unknown. The studies described herein were performed to investigate the possibility that some of the actions of EGF may be mediated through the estrogen receptor. A specific estrogen receptor (ER) antagonist inhibited estrogenlike effects of EGF in the mouse uterus, specifically induction of DNA synthesis and phosphatidylinositol turnover. In addition, EGF elicited enhanced nuclear localization of uterine ER and formation of a unique nuclear form of ER that is present after estrogen treatment. These in vivo observations indicated that EGF may elicit some of its actions by activation of nuclear ER. Thus, the effect of peptide growth factors on activation of a consensus estrogen response element was assessed in Ishikawa human endometrial adenocarcinoma cells, which contain negligible ER levels, and in BG-1 human ovarian adenocarcinoma cells, which contain abundant ER. EGF and TGF alpha induced transcriptional activation of a consensus estrogen response element (ERE) in an ER-dependent manner in both cell types. In addition, insulinlike growth factor I (IGF-I) was as potent as 17 beta-estradiol in BG-1 cells. Synergism between growth factors and estrogen was observed in both cell types, although synergism was not observed between the different classes of growth factors [i.e., transforming growth factor alpha (TGF alpha) and IGF-I] in BG-1 cells. The most potent activator of ERE-dependent transcription was a protein kinase C activator (TPA), which acted synergistically with 17 beta-estradiol. A protein kinase C inhibitor abolished the effect of TPA but not that of 17 beta-estradiol, IGF-I, or TGF alpha. A protein kinase A activator elicited ER-dependent activation of transcription and did not synergize with estrogen or growth factors. In conclusion, some physiologic actions of peptide growth factors are dependent on ER. Indeed, growth factors are capable of eliciting ER-dependent activation of an ERE. Both the protein kinase A and protein kinase C pathways can elicit ER-dependent transcriptional activation; however, it is unlikely that these pathways mediate the effects of peptide growth factors on the ER in BG-1 cells.

Full text

PDF
35

Images in this article

36Figure 1.
on p.36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronica S. M., Katzenellenbogen B. S. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology. 1991 Apr;128(4):2045–2052. doi: 10.1210/endo-128-4-2045. [DOI] [PubMed] [Google Scholar]
  2. Aronica S. M., Katzenellenbogen B. S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol. 1993 Jun;7(6):743–752. doi: 10.1210/mend.7.6.7689695. [DOI] [PubMed] [Google Scholar]
  3. Cho H., Katzenellenbogen B. S. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol Endocrinol. 1993 Mar;7(3):441–452. doi: 10.1210/mend.7.3.7683375. [DOI] [PubMed] [Google Scholar]
  4. Curtis S. W., Korach K. S. Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes. Mol Endocrinol. 1990 Feb;4(2):276–286. doi: 10.1210/mend-4-2-276. [DOI] [PubMed] [Google Scholar]
  5. DiAugustine R. P., Petrusz P., Bell G. I., Brown C. F., Korach K. S., McLachlan J. A., Teng C. T. Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology. 1988 Jun;122(6):2355–2363. doi: 10.1210/endo-122-6-2355. [DOI] [PubMed] [Google Scholar]
  6. Dickson R. B., Lippman M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev. 1987 Feb;8(1):29–43. doi: 10.1210/edrv-8-1-29. [DOI] [PubMed] [Google Scholar]
  7. Gardner R. M., Verner G., Kirkland J. L., Stancel G. M. Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J Steroid Biochem. 1989 Mar;32(3):339–343. doi: 10.1016/0022-4731(89)90205-7. [DOI] [PubMed] [Google Scholar]
  8. Golding T. S., Korach K. S. Nuclear estrogen receptor molecular heterogeneity in the mouse uterus. Proc Natl Acad Sci U S A. 1988 Jan;85(1):69–73. doi: 10.1073/pnas.85.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Horigome T., Ogata F., Golding T. S., Korach K. S. Estradiol-stimulated proteolytic cleavage of the estrogen receptor in mouse uterus. Endocrinology. 1988 Nov;123(5):2540–2548. doi: 10.1210/endo-123-5-2540. [DOI] [PubMed] [Google Scholar]
  10. Huet-Hudson Y. M., Chakraborty C., De S. K., Suzuki Y., Andrews G. K., Dey S. K. Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells. Mol Endocrinol. 1990 Mar;4(3):510–523. doi: 10.1210/mend-4-3-510. [DOI] [PubMed] [Google Scholar]
  11. Ignar-Trowbridge D. M., Hughes A. R., Putney J. W., Jr, McLachlan J. A., Korach K. S. Diethylstilbestrol stimulates persistent phosphatidylinositol lipid turnover by an estrogen receptor-mediated mechanism in immature mouse uterus. Endocrinology. 1991 Nov;129(5):2423–2430. doi: 10.1210/endo-129-5-2423. [DOI] [PubMed] [Google Scholar]
  12. Ignar-Trowbridge D. M., Nelson K. G., Bidwell M. C., Curtis S. W., Washburn T. F., McLachlan J. A., Korach K. S. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4658–4662. doi: 10.1073/pnas.89.10.4658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ignar-Trowbridge D. M., Teng C. T., Ross K. A., Parker M. G., Korach K. S., McLachlan J. A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol. 1993 Aug;7(8):992–998. doi: 10.1210/mend.7.8.8232319. [DOI] [PubMed] [Google Scholar]
  14. Katzenellenbogen B. S., Norman M. J. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen. Endocrinology. 1990 Feb;126(2):891–898. doi: 10.1210/endo-126-2-891. [DOI] [PubMed] [Google Scholar]
  15. Kawamoto T., Sato J. D., Le A., Polikoff J., Sato G. H., Mendelsohn J. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1337–1341. doi: 10.1073/pnas.80.5.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Korach K. S. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems. Endocrinology. 1979 May;104(5):1324–1332. doi: 10.1210/endo-104-5-1324. [DOI] [PubMed] [Google Scholar]
  17. Krusekopf S., Chauchereau A., Milgrom E., Henderson D., Cato A. C. Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. J Steroid Biochem Mol Biol. 1991;40(1-3):239–245. doi: 10.1016/0960-0760(91)90188-b. [DOI] [PubMed] [Google Scholar]
  18. Lillie J. W., Green M. R. Transcription activation by the adenovirus E1a protein. Nature. 1989 Mar 2;338(6210):39–44. doi: 10.1038/338039a0. [DOI] [PubMed] [Google Scholar]
  19. Lingham R. B., Stancel G. M., Loose-Mitchell D. S. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol. 1988 Mar;2(3):230–235. doi: 10.1210/mend-2-3-230. [DOI] [PubMed] [Google Scholar]
  20. Michels K. M., Lee W. H., Seltzer A., Saavedra J. M., Bondy C. A. Up-regulation of pituitary [125I]insulin-like growth factor-I (IGF-I) binding and IGF binding protein-2 and IGF-I gene expression by estrogen. Endocrinology. 1993 Jan;132(1):23–29. doi: 10.1210/endo.132.1.7678216. [DOI] [PubMed] [Google Scholar]
  21. Mukku V. R., Stancel G. M. Regulation of epidermal growth factor receptor by estrogen. J Biol Chem. 1985 Aug 15;260(17):9820–9824. [PubMed] [Google Scholar]
  22. Murphy L. J., Ghahary A. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev. 1990 Aug;11(3):443–453. doi: 10.1210/edrv-11-3-443. [DOI] [PubMed] [Google Scholar]
  23. Murphy L. J., Murphy L. C., Friesen H. G. Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol. 1987 Jul;1(7):445–450. doi: 10.1210/mend-1-7-445. [DOI] [PubMed] [Google Scholar]
  24. Nelson K. G., Takahashi T., Bossert N. L., Walmer D. K., McLachlan J. A. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):21–25. doi: 10.1073/pnas.88.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nelson K. G., Takahashi T., Lee D. C., Luetteke N. C., Bossert N. L., Ross K., Eitzman B. E., McLachlan J. A. Transforming growth factor-alpha is a potential mediator of estrogen action in the mouse uterus. Endocrinology. 1992 Oct;131(4):1657–1664. doi: 10.1210/endo.131.4.1396310. [DOI] [PubMed] [Google Scholar]
  26. Power R. F., Lydon J. P., Conneely O. M., O'Malley B. W. Dopamine activation of an orphan of the steroid receptor superfamily. Science. 1991 Jun 14;252(5012):1546–1548. doi: 10.1126/science.2047861. [DOI] [PubMed] [Google Scholar]
  27. Power R. F., Mani S. K., Codina J., Conneely O. M., O'Malley B. W. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science. 1991 Dec 13;254(5038):1636–1639. doi: 10.1126/science.1749936. [DOI] [PubMed] [Google Scholar]
  28. Smith C. L., Conneely O. M., O'Malley B. W. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6120–6124. doi: 10.1073/pnas.90.13.6120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Vignon F., Bouton M. M., Rochefort H. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun. 1987 Aug 14;146(3):1502–1508. doi: 10.1016/0006-291x(87)90819-9. [DOI] [PubMed] [Google Scholar]
  30. Wakeling A. E., Bowler J. Novel antioestrogens without partial agonist activity. J Steroid Biochem. 1988 Oct;31(4B):645–653. doi: 10.1016/0022-4731(88)90014-3. [DOI] [PubMed] [Google Scholar]
  31. Washburn T., Hocutt A., Brautigan D. L., Korach K. S. Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues. Mol Endocrinol. 1991 Feb;5(2):235–242. doi: 10.1210/mend-5-2-235. [DOI] [PubMed] [Google Scholar]
  32. Welander C. E., Morgan T. M., Homesley H. D., Trotta P. P., Spiegel R. J. Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay. Int J Cancer. 1985 Jun 15;35(6):721–729. doi: 10.1002/ijc.2910350605. [DOI] [PubMed] [Google Scholar]
  33. Wu D. G., Wang L. H., Sato G. H., West K. A., Harris W. R., Crabb J. W., Sato J. D. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site. J Biol Chem. 1989 Oct 15;264(29):17469–17475. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES